N.C.G.S. § 130A-453.41 — revision history

Text is never overwritten. Each amendment lands as a new version row with its own effective range.

1. Version 1 — 2026-08-08 to present

   Scraped from ncleg.gov; The General Statutes include changes through S.L. 2026-7.

   The following definitions apply in this Article: (1) DEHP. - Di(2-ethylhexyl) phthalate. (2) Health care practitioner. - An individual who is authorized to practice some component of the healing arts by a license, permit, certificate, or registration issued by a State licensing agency or board. (3) Intentionally added DEHP. - DEHP that a manufacturer has intentionally added to a product and that has a functional or technical effect on the product. (4) Intravenous solution container. - A container used to house medicine, fluid, or nutrition therapy that is intravenously delivered to a patient in a hospital, outpatient facility, or other health care facility. (5) Intravenous tubing. - Tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant. (6) Ortho-phthalate. - A class of chemicals that are esters of ortho-phthalic acid, including DEHP or any of the following: a. Benzyl butyl phthalate (BBP). b. Dibutyl phthalate (DBP). c. Dicyclohexyl phthalate (DCHP). d. Diethyl phthalate (DEP). e. Diisobutyl phthalate (DIBP). f. Diisodecyl phthalate (DIDP). g. Diisononyl phthalate (DINP). h. Di-n-hexyl phthalate (DnHP). i. Di-n-octyl phthalate (DNOP). j. Di-n-pentyl phthalate (DnPP). k. Diisoheptyl phthalate (DIHP). (7) Unintentionally added DEHP. - DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.  (2025-60, s. 3(a).)